
Brian E. Mcdowell
Examiner (ID: 5411, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1663 |
| Issued Applications | 1042 |
| Pending Applications | 129 |
| Abandoned Applications | 533 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16557107
[patent_doc_number] => 20210002255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => TLR7/8 ANTAGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/948432
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16948432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/948432 | TLR7/8 antagonists and uses thereof | Sep 17, 2020 | Issued |
Array
(
[id] => 16557130
[patent_doc_number] => 20210002278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => BICYCLIC HETEROCYCLIC DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/023782
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/023782 | Bicyclic heterocyclic derivatives | Sep 16, 2020 | Issued |
Array
(
[id] => 16557127
[patent_doc_number] => 20210002275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => PROCESS FOR PREPARATION OF PALBOCICLIB
[patent_app_type] => utility
[patent_app_number] => 17/019918
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/019918 | PROCESS FOR PREPARATION OF PALBOCICLIB | Sep 13, 2020 | Abandoned |
Array
(
[id] => 16539318
[patent_doc_number] => 20200405731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS
[patent_app_type] => utility
[patent_app_number] => 17/016158
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016158 | METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS | Sep 8, 2020 | Pending |
Array
(
[id] => 16525201
[patent_doc_number] => 20200399281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/014533
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/014533 | Pyrazolo[1,5-a]pyrazin-4-yl derivatives | Sep 7, 2020 | Issued |
Array
(
[id] => 16688259
[patent_doc_number] => 20210070735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/012891
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012891 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | Sep 3, 2020 | Abandoned |
Array
(
[id] => 17866957
[patent_doc_number] => 20220289692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => NLRP3 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/636021
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636021 | NLRP3 INHIBITORS | Sep 3, 2020 | Pending |
Array
(
[id] => 18725719
[patent_doc_number] => 20230339911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => PYRIDAZINONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/023241
[patent_app_country] => US
[patent_app_date] => 2020-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023241 | PYRIDAZINONE COMPOUNDS | Aug 26, 2020 | Pending |
Array
(
[id] => 17928264
[patent_doc_number] => 20220323389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND INFLAMMATORY STEATOHEPATITIS WITH SLC25A1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/638383
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638383
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638383 | TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND INFLAMMATORY STEATOHEPATITIS WITH SLC25A1 INHIBITORS | Aug 25, 2020 | Pending |
Array
(
[id] => 17193074
[patent_doc_number] => 11161814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Compounds for modulating mitochondrial function
[patent_app_type] => utility
[patent_app_number] => 17/002308
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 51
[patent_no_of_words] => 15132
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002308
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/002308 | Compounds for modulating mitochondrial function | Aug 24, 2020 | Issued |
Array
(
[id] => 16483913
[patent_doc_number] => 20200377514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/996502
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996502 | KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION | Aug 17, 2020 | Abandoned |
Array
(
[id] => 18187475
[patent_doc_number] => 11578042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => 3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide
[patent_app_type] => utility
[patent_app_number] => 16/990176
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 26940
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990176
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990176 | 3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl)carbamimidoyl)pyrazine-2-carboxamide | Aug 10, 2020 | Issued |
Array
(
[id] => 16452450
[patent_doc_number] => 20200361876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => PROCESS FOR THE PREPARATION OF DIPHENYLPYRAZINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/984467
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984467
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984467 | Process for the preparation of diphenylpyrazine derivatives | Aug 3, 2020 | Issued |
Array
(
[id] => 16452504
[patent_doc_number] => 20200361930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => BIFUNCTIONAL MOLECULES THAT DEGRADE EGFR
[patent_app_type] => utility
[patent_app_number] => 16/984987
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984987 | BIFUNCTIONAL MOLECULES THAT DEGRADE EGFR | Aug 3, 2020 | Abandoned |
Array
(
[id] => 17921569
[patent_doc_number] => 11464790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Triterpenoids with HIV maturation inhibitory activity
[patent_app_type] => utility
[patent_app_number] => 16/983052
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52847
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/983052 | Triterpenoids with HIV maturation inhibitory activity | Aug 2, 2020 | Issued |
Array
(
[id] => 17665250
[patent_doc_number] => 11358931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Selective androgen receptor modulators (SARMs) and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/983617
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63103
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/983617 | Selective androgen receptor modulators (SARMs) and uses thereof | Aug 2, 2020 | Issued |
Array
(
[id] => 18582834
[patent_doc_number] => 20230265089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => QUINOLINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/003758
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003758
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003758 | QUINOLINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS, AND METHODS OF USE THEREOF | Jul 30, 2020 | Pending |
Array
(
[id] => 16450912
[patent_doc_number] => 20200360338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => METHOD FOR ACTIVATING ENERGY METABOLISM IN MUSCLE CELLS BY ADMINISTERING TO HUMAN BEINGS AT LEAST ONE ACTIVE SUBSTANCE COMPRISING METHOXYFLAVONE
[patent_app_type] => utility
[patent_app_number] => 16/941633
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16941633
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/941633 | METHOD FOR ACTIVATING ENERGY METABOLISM IN MUSCLE CELLS BY ADMINISTERING TO HUMAN BEINGS AT LEAST ONE ACTIVE SUBSTANCE COMPRISING METHOXYFLAVONE | Jul 28, 2020 | Abandoned |
Array
(
[id] => 17882638
[patent_doc_number] => 20220298115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2)
[patent_app_type] => utility
[patent_app_number] => 17/629497
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629497 | SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) | Jul 23, 2020 | Abandoned |
Array
(
[id] => 17867052
[patent_doc_number] => 20220289787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => DIMER COMBINATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/629733
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629733 | DIMER COMBINATIONS AND USES THEREOF | Jul 23, 2020 | Pending |